Analysts: Alexza Pharmaceuticals Inc (ALXA.O)

ALXA.O on Consolidated Issue listed on NASDAQ Global Market

3.54USD
21 Aug 2014
Price Change (% chg)

$-0.01 (-0.28%)
Prev Close
$3.55
Open
$3.58
Day's High
$3.62
Day's Low
$3.50
Volume
109,099
Avg. Vol
126,068
52-wk High
$5.93
52-wk Low
$3.41

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.76 December 21 Aug 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 2 2 2
(3) HOLD 1 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 1.67 1.67 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 2 3.19 4.86 1.52 4.35
Quarter Ending Dec-14 2 4.14 7.07 1.21 7.39
Year Ending Dec-14 4 11.13 15.86 6.38 17.50
Year Ending Dec-15 3 30.54 45.91 16.19 47.71
Earnings (per share)
Quarter Ending Sep-14 2 -0.76 -0.75 -0.78 -0.37
Quarter Ending Dec-14 2 -0.68 -0.56 -0.80 -0.21
Year Ending Dec-14 4 -2.29 -2.13 -2.55 -1.33
Year Ending Dec-15 3 -1.52 -1.08 -1.90 -0.24

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-14 2.24 1.48 0.76 33.84
Quarter Ending Mar-14 1.91 2.17 0.25 13.14
Quarter Ending Dec-13 1.12 1.31 0.19 17.14
Quarter Ending Sep-13 1.98 2.17 0.18 9.23
Quarter Ending Jun-13 14.17 40.83 26.67 188.25
Earnings (per share)
Quarter Ending Jun-14 -0.67 -0.34 0.33 -49.00
Quarter Ending Mar-14 -0.63 -0.62 0.01 -2.36
Quarter Ending Dec-13 -0.76 -0.33 0.43 -56.58
Quarter Ending Sep-13 -0.54 -0.72 0.18 -33.33
Quarter Ending Jun-13 0.09 -0.21 0.30 333.33

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 3.19 3.19 3.58 3.58 4.35
Quarter Ending Dec-14 4.14 4.14 5.64 5.64 7.39
Year Ending Dec-14 11.13 11.13 12.03 12.03 17.50
Year Ending Dec-15 30.54 30.54 36.81 36.81 47.71
Earnings (per share)
Quarter Ending Sep-14 -0.76 -0.76 -0.55 -0.55 -0.37
Quarter Ending Dec-14 -0.68 -0.68 -0.42 -0.42 -0.21
Year Ending Dec-14 -2.29 -2.29 -2.23 -2.23 -1.33
Year Ending Dec-15 -1.52 -1.52 -1.10 -1.10 -0.24

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-14 0 0 0 1
Quarter Ending Dec-14 0 0 0 2
Year Ending Dec-14 0 0 0 2
Year Ending Dec-15 0 0 1 1
Earnings
Quarter Ending Sep-14 0 0 0 2
Quarter Ending Dec-14 0 0 0 2
Year Ending Dec-14 0 0 1 1
Year Ending Dec-15 0 0 0 2

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks